Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects

NCT02468908 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Alveolar Proteinosis
Bronchiectasis
Cystic Fibrosis
Acute Respiratory Distress Syndrome

Interventions

DRUG: Molgramostim
DRUG: Placebo

Sponsor

Savara Inc.

Collaborators

[object Object]